Diabetes Breakthrough: IIT Kanpur Scientists Discover How Immune Cells Switch Off Insulin In Minutes
In a discovery that could change how scientists understand diabetes, researchers at the Indian Institute of Technology (IIT) Kanpur have found that certain immune cells inside the pancreas can interfere with insulin rele
Ni Oliver Fredrick··147K nabasa
Diabetes Breakthrough: IIT Kanpur Scientists Discover How Immune Cells Switch Off Insulin In Minutes
In a discovery that could change how scientists understand diabetes, researchers at the Indian Institute of Technology (IIT) Kanpur have found that certain immune cells inside the pancreas can interfere with insulin release within minutes.
The researchers have identified how these immune cells communicate with insulin-producing cells and prevent them from releasing insulin normally. The discovery could open a new direction for developing treatments to protect insulin production, particularly in people with obesity and type 2 diabetes.
To understand the significance of the discovery, it is important to understand the role of the pancreas in controlling blood sugar.
The pancreas is an organ located behind the stomach. One of its most important functions is to produce insulin, a hormone that helps the body use sugar from food for energy. After a meal, when blood sugar levels rise, the pancreas releases insulin into the bloodstream. Insulin helps sugar move from the blood into the body’s cells, keeping blood glucose levels under control.
The pancreas contains clusters of cells called islets. These include beta cells, which produce and release insulin, and other cells that help regulate the functioning of the pancreas. Among them are immune cells called macrophages, which normally help protect tissues and maintain their health.
The IIT Kanpur study has discovered that these macrophages can also send signals to neighbouring beta cells and interfere with their ability to release insulin.
Until now, scientists largely believed that obesity-related inflammation gradually damaged insulin-producing cells over months or years. However, the new research has revealed a much-faster process in which immune cells can suppress insulin release within minutes.
“We discovered that immune cells that are present next to beta cells can switch off insulin release within minutes,” said Dr Sai Prasad Pydi, Assistant Professor at the Department of Biological Sciences and Bioengineering, IIT Kanpur, who led the research.
“And they do it without giving any of the classical inflammation signals we have been studying for decades. The findings change our fundamental understanding of how immune cells influence insulin production. The effect is not slow damage from inflammation but instruction that is delivered in minutes,” he added.
How Does The Process Work?
The researchers found that the process begins when a particular signalling pathway in the immune cells gets activated. These cells then release special fat molecules called sphingolipids.
These fat molecules travel to neighbouring insulin-producing beta cells and enter them through a specific passage, or transporter, on their surface. Once inside, they interfere with the machinery that helps beta cells release insulin.
In simple terms, the immune cells send a chemical message that disrupts the normal functioning of insulin-producing cells, reducing the amount of insulin released into the bloodstream.
The team also identified a receptor, or a protein that receives signals, called GPR18 on the immune cells. It acts like a switch that starts this process.
In experiments, researchers found that blocking this receptor or interrupting the steps that follow it helped restore insulin release.
The team used a specialised genetic technique to switch the process on and off in laboratory mice. When activated, insulin release dropped significantly. When the pathway was switched off, insulin secretion improved.
Why Is The Discovery Important?
An important part of the research was establishing whether the same process also takes place in humans. Working with the Indiana Biosciences Research Institute in the United States, the IIT Kanpur researchers examined donated human pancreatic tissue.
They found that the GPR18 receptor was present in high amounts in immune cells within the pancreas. When the researchers activated the pathway in human pancreatic tissue, insulin release was also reduced.
“The fact that this works the same way in human tissue is what makes it exciting. It is not just a finding in tissues of laboratory mice, but a real biological circuit that could be targeted with a drug,” Dr Pydi said.
The researchers believe that blocking this process could eventually help protect insulin-producing cells and improve insulin release in people with obesity and type 2 diabetes.
The discovery also identifies three possible targets for future medicines: blocking the GPR18 receptor, stopping the release of the fat molecules, or preventing these molecules from entering insulin-producing cells. However, the research does not mean that a new diabetes medicine or cure is immediately available. Further studies and clinical research will be required to establish whether blocking this pathway can safely benefit patients.
The research was jointly led by Simran Singh and Ashish Kumar, who were the co-first authors, under the supervision of Dr Sai Prasad Pydi.